<DOC>
	<DOCNO>NCT00066001</DOCNO>
	<brief_summary>The purpose study determine clinical microbiological effect systemically administer metronidazole alone combination professional plaque removal periodontally diseased patient .</brief_summary>
	<brief_title>Microbial Associations Periodontal Health Disease</brief_title>
	<detailed_description>Major goal periodontal research differentiate pathogenic host compatible plaque microbiotas optimize treatment convert former latter . To end , previous award period composition supra subgingival plaque , association among specie within supra subgingival plaque , difference plaques healthy diseased individual determine . One major find frequent detection anaerobic periodontal pathogen low number supragingival plaque periodontally diseased less extent healthy subject . Weekly professional supragingival plaque removal 3 month 18 periodontitis subject demonstrate astonish reduction subgingival microbiota maintain 9 month cessation professional program . The composition microbiota 12 month subject similar find periodontal health . In another study , systemically administer metronidazole produce similar effect . Thus , SA1 2 year randomize clinical trial perform compare effect 1 ) SRP alone combination 2 ) weekly professional supragingival plaque removal , 3 ) systemically administer metronidazole 4 ) combination 2 clinical parameter supra subgingival plaque composition . 200 periodontitis patient receive SRP local anaesthesia randomly assign 4 treatment group . All subject evaluate clinically supra subgingival plaque composition 2 week , 3 , 6 , 12 , 18 24 month . Supra subgingival plaque sample take separately mesial aspect tooth evaluate individually content 40 bacterial specie use checkerboard DNA-DNA hybridization provide 3.6 million bacterial count . The result determine beneficial effect individual therapy persist beyond one year whether combined treatment produce even great benefit patient .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Periodontal Diseases</mesh_term>
	<mesh_term>Gingival Diseases</mesh_term>
	<mesh_term>Metronidazole</mesh_term>
	<criteria>Inclusion : &gt; 35 year age &gt; 20 teeth &gt; 5 % site ( approx . 8 site ) pocket depth &gt; 4 mm / 5 % site attachment level &gt; 4 mm Exclusion : &gt; 50 % site pocket depth attachment level &gt; 4 mm Pregnancy lactation Periodontal antibiotic therapy previous 12 month Any systemic condition might influence course periodontal disease treatment ( e.g . diabetes , AIDS ) Any systemic condition require antibiotic coverage routine periodontal procedure ( e.g . heart condition , joint replacement etc . ) Any know allergy metronidazole</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>